Equities

IRRAS

SE0008321202

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 07:59:43 2023-11-03 am EDT			5-day change	1st Jan Change
0.1604 ^SEK	-1.11%		-.--%	-.--%

2023	IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index	CI
2023	IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index	CI

IRRAS AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 10, 2022 at 02:00 am EST

IRRAS AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 11 million compared to SEK 6.1 million a year ago. Net loss was SEK 50.1 million compared to SEK 26.9 million a year ago.
For the nine months, sales was SEK 29.4 million compared to SEK 15.2 million a year ago. Net loss was SEK 120.3 million compared to SEK 92.9 million a year ago.

Latest news about IRRAS AB

IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index	23-10-24	CI
IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index	23-10-24	CI
Irras Obtains Nasdaq Approval for Delisting in Stockholm	23-10-23	MT
Sweden's Irras Files for Delisting as Privatization Nears Completion	23-10-20	MT
Irras Obtains Extension for SEK20 Million Loan	23-10-16	MT
Irras Shareholder Extends, Upsizes Loan	23-09-15	MT
Legacy Capital Partners S.C.A. I, Spetses Investments Ltd, Bacara Holdings Limited, Lexington Holding Assets Ltd and Panormos Holding Limited completed the acquisition of a 26.6% stake in IRRAS AB (OM : IRRAS).	23-09-03	CI
Swedish Medical Device Company Irras Warns of Possible High Risk of Insolvency	23-08-24	MT
IR Holding Bidco Extends Acceptance Period for Irras Takeover	23-08-22	MT
Transcript : IRRAS AB, Q2 2023 Earnings Call, Aug 04, 2023	23-08-04
Irras Extends Loan Agreement with Second-biggest Shareholder	23-08-04	MT
IRRAS AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04	CI
Irras' Independent Bid Panel Backs IR Holding's SEK143 Million Takeover Offer	23-07-24	MT
Irras Surges 19% on Takeover Offer From IR Holding Bidco	23-06-30	MT
Legacy Capital Partners S.C.A. I, Spetses Investments Ltd, Bacara Holdings Limited, Lexington Holding Assets Ltd and Panormos Holding Limited agreed to acquire IRRAS AB (OM : IRRAS) for approximately SEK 140 million.	23-06-29	CI
IRRAS AB Provides Sales Guidance for the Second Quarter of 2024	23-06-29	CI
IRRAS AB Shifts Commercial Strategy to Focus Resources on United States Market Opportunity	23-06-29	CI
IRRAS AB Announces Resignation of Eva Nilsagård as a Board Member	23-06-01	CI
Transcript : IRRAS AB, Q1 2023 Earnings Call, May 17, 2023	23-05-17
IRRAS AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-17	CI
IRRAS AB Auditor Raises 'Going Concern' Doubt	23-04-26	CI
Transcript : IRRAS AB, Q4 2022 Earnings Call, Feb 16, 2023	23-02-16
IRRAS AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-16	CI
IRRAS AB Announces That the Publication of the First Comparative Study	23-02-13	CI
IRRAS Receives US FDA 510(K) Clearance for Its Next Generation IRRAflow Control Unit	22-12-12	CI

Chart IRRAS AB

Duration

Period

More charts

Company Profile

Irras AB is a Sweden-based medical technology company. It offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Companyâs shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Ratings for IRRAS AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
IRRAS AB	-.--%	16.98M
STRYKER CORPORATION	+11.76%	127B
SMITH & NEPHEW PLC	-5.10%	11.32B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.02%	9.04B
GLAUKOS CORPORATION	+38.12%	5.56B
INSPIRE MEDICAL SYSTEMS, INC.	-23.70%	4.72B
AXONICS, INC.	+8.55%	3.45B
ENOVIS CORPORATION	-6.44%	2.86B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-5.85%	2.07B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-11.84%	2.04B

Medical Devices & Implants